Literature DB >> 21315300

Causes of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.

Anna Nyhlén1, Mats Fridell, Morten Hesse, Peter Krantz.   

Abstract

AIMS: To evaluate premature mortality and causes of death from young adulthood to middle age in a cohort of drug users followed during almost four decades.
DESIGN: Follow-up study of a consecutive cohort of patients with drug abuse/dependence.
METHODS: A cohort of 561 drug abusers, admitted to a detoxification and short-term rehabilitation unit 1970-1978 was followed to December 31st, 2006. Standardized interviews and hospital records with toxicological analyses were used for demographic data, substance use and psychiatric diagnoses at admission. For Follow-up analyses, autopsy protocols including toxicology tests and death certificates were obtained for assessment of causes of death which were coded according to ICD-10. Age-group standardized mortality ratios were calculated independently for both sexes.
RESULTS: 204 persons (36.4%) were deceased by 2006. SMR was 5.94 for the cohort. Compared to an age- and gender-matched population, the risk of premature death was about eighteen times higher between the ages of 20-44 and about five times higher from 45 up to the age of 69. Of 120 (59%) drug-related deaths, 43 were opiate overdoses, and 3 were overdose from amphetamine. A total of 53 (26%) persons died violent deaths: 39 suicides, of which 25 were drug-related, 3 homicides and 12 accidents. The Swedish national causes of death register underestimated drug-related death by 37% and suicide by 85% compared to the results from this study.
CONCLUSIONS: The cohort of drug abusers had an increased risk of premature often drug-related and violent death well into middle age, and to a great extent the drug addicts died from the same drug they had abused when they were first admitted for treatment. The underestimation of drug-related death and suicide in some national death cause registers could be reduced if the doctor routinely records ICD codes when issuing death certificates and autopsy protocols.
Copyright © 2011 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21315300     DOI: 10.1016/j.jflm.2011.01.003

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  14 in total

1.  Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Authors:  Emily Stockings; Lucy Thi Tran; Thomas Santo; Amy Peacock; Sarah Larney; Damian Santomauro; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2019-07-28       Impact factor: 6.526

2.  Cardiovascular disease among people with drug use disorders.

Authors:  Birgitte Thylstrup; Thomas Clausen; Morten Hesse
Journal:  Int J Public Health       Date:  2015-06-24       Impact factor: 3.380

3.  Potential Years of Life Lost Due to Premature Mortality Among Treatment-Seeking Illicit Drug Users in Finland.

Authors:  Ifeoma N Onyeka; Caryl M Beynon; Ilkka Vohlonen; Jari Tiihonen; Jaana Föhr; Kimmo Ronkainen; Jussi Kauhanen
Journal:  J Community Health       Date:  2015-12

4.  Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Paolo Mannelli; Dan G Blazer
Journal:  Subst Abuse Rehabil       Date:  2011-05

5.  Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.

Authors:  Anna Nyhlén; Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz
Journal:  BMC Psychiatry       Date:  2011-07-30       Impact factor: 3.630

6.  Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: a cohort study of outcome for women and men after seven years.

Authors:  Leif Öhlin; Mats Fridell; Anna Nyhlén
Journal:  BMC Psychiatry       Date:  2015-03-24       Impact factor: 3.630

7.  Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.

Authors:  Ina H Heiberg; Bjarne K Jacobsen; Ragnar Nesvåg; Jørgen G Bramness; Ted Reichborn-Kjennerud; Øyvind Næss; Eivind Ystrom; Christina M Hultman; Anne Høye
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

8.  Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study.

Authors:  Arne Jan Hjemsæter; Jørgen G Bramness; Robert Drake; Ivar Skeie; Bent Monsbakken; Jūratė Šaltytė Benth; Anne S Landheim
Journal:  BMC Psychiatry       Date:  2019-03-28       Impact factor: 3.630

9.  Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users.

Authors:  Linn Gjersing; Anne Line Bretteville-Jensen
Journal:  BMC Public Health       Date:  2014-05-10       Impact factor: 3.295

Review 10.  Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis.

Authors:  Robert W Aldridge; Alistair Story; Stephen W Hwang; Merete Nordentoft; Serena A Luchenski; Greg Hartwell; Emily J Tweed; Dan Lewer; Srinivasa Vittal Katikireddi; Andrew C Hayward
Journal:  Lancet       Date:  2017-11-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.